CollabRx Chief Medical Officer to Moderate Panel at Personalized Medicine World Conference (PMWC) 2016
December 10 2015 - 07:00AM
CollabRx, Inc. a leading clinical decision support company and
wholly owned subsidiary of Rennova Health, Inc. (NASDAQ:RNVA) today
announced that its Chief Medical Officer, George Lundberg, MD, will
chair this year's Personalized Medicine World Conference, Silicon
Valley session titled, "The Role of Practicing Pathologists in
Personalized Medicine."
The January 25, 2016 track two session will start at 10:30 a.m.
Pacific time. Panel participants include Steve Miller, PhD,
Director of the Clinical Microbiology Laboratory at University
California San Francisco, Kojo Elenitoba-Johnson, MD, Professor at
the University of Pennsylvania's Perelman School of Medicine and
Alexander Judkins, MD, PhD, Head of Pathology and Laboratory
Medicine at Children's Hospital, Los Angeles.
In addition to his work at CollabRx, Dr. Lundberg is also
Editor-at-Large for Medscape and a consulting professor at Stanford
University. A frequent lecturer and radio and television guest, and
a member of the National Academy of Medicine, the Industry Standard
dubbed Dr. Lundberg "Online Healthcare's Medicine Man" in 2000 and
from 1982-1999 he was Editor in Chief of JAMA (The Journal of the
American Medical Association).
"George's years as a practicing physician and experience working
with pathologists in today's personalized medicine-driven world
will make him a great panel moderator," said Thomas Mika, CollabRx
CEO. "His current role at CollabRx where he helps deliver expert
solutions in precision oncology that enable physicians,
laboratories, payers, and providers to achieve standardized,
evidence-based care and superior clinical outcomes coupled with
insights from Dr. Judkins, Dr. Miller and Dr. Elenitoba-Johnson
will comprise a highly informational session."
The Personalized Medicine World Conference (PMWC) is an
independent conference that brings together experts across
healthcare and biotechnology sectors to help further the adoption
of personalized medicine in the clinic.This year's Silicon Valley
conference will be held January 24th through the 27st at the
Computer History Museum in Mountain View, California.
About CollabRx, Inc.
CollabRx is a clinical decision-support company delivering
expert solutions in precision oncology that enable physicians,
laboratories, payers, and providers to achieve standardized,
evidence-based care and superior clinical outcomes. CollabRx uses
information technology to aggregate and contextualize the world's
knowledge on genomics-based medicine with specific insights from
the nation's top cancer experts, starting with the area of greatest
need: advanced cancers in patients who have effectively exhausted
the standard of care. More information may be obtained at
http://www.collabrx.com.
About Rennova Health, Inc.
Rennova Health (Nasdaq:RNVA) owns and operates five diagnostics
laboratories across the United States that provide clinical testing
services specializing in toxicology testing for pain management
clinics, drug and alcohol rehabilitation facilities and
neurotransmitter testing. It offers its customers a complete,
turnkey software product including: a proprietary laboratory
ordering and reporting application, an advanced laboratory
information management system, electronic health records, and an
industry-leading platform for interpreting and reporting complex
test results to physicians. Rennova's software is differentiated
from that of its competitors by the breadth of its services, each
of which is branded separately and is made available to physician
groups in whole or in part. The software permits efficient and easy
ordering and reporting, electronic health records integration,
medical billing services and compliance, and diagnostic
interpretation. For more information see www.rennovahealth.com.
CONTACT: Media Contact:
Marla Kertzman for CollabRx
408 482 3546
marla@thoroughbred-communications.com
Rennova Health Company Contact:
Tiffany VanDeMark
Director of Marketing
561 666 9821
tvandemark@rennovahealthms.com
(MM) (NASDAQ:CLRX)
Historical Stock Chart
From Feb 2024 to Mar 2024
(MM) (NASDAQ:CLRX)
Historical Stock Chart
From Mar 2023 to Mar 2024